Carteolol HCl en es it fr

Carteolol HCl Brand names, Carteolol HCl Analogs

Carteolol HCl Brand Names Mixture

  • No information avaliable

Carteolol HCl Chemical_Formula


Carteolol HCl RX_link

Carteolol HCl fda sheet

Carteolol HCl msds (material safety sheet)

Carteolol HCl Synthesis Reference

No information avaliable

Carteolol HCl Molecular Weight

292.373 g/mol

Carteolol HCl Melting Point

No information avaliable

Carteolol HCl H2O Solubility

No information avaliable

Carteolol HCl State


Carteolol HCl LogP


Carteolol HCl Dosage Forms

Ophthalmic Solution (1%)

Carteolol HCl Indication

For the treatment of intraocular hypertension and chronic open-angle glaucoma

Carteolol HCl Pharmacology

Carteolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity. Carteolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. Carteolol reduces intraocular pressure with little or no effect on pupil size or accommodation in contrast to the miosis which cholinergic agents are known to produce.

Carteolol HCl Absorption

No information avaliable

Carteolol HCl side effects and Toxicity

The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.

Carteolol HCl Patient Information

No information avaliable

Carteolol HCl Organisms Affected

Humans and other mammals